M Meester1, T J Tobias2, M Bouwknegt3, N E Kusters4, J A Stegeman2, W H M van der Poel4. 1. Farm Animal Health unit, Department of Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands. m.meester@uu.nl. 2. Farm Animal Health unit, Department of Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands. 3. Vion Food Group, Boxtel, the Netherlands. 4. Wageningen Bioveterinary Research, Lelystad, the Netherlands.
Abstract
BACKGROUND: Hepatitis E virus (HEV) genotype 3 and 4 is a zoonosis that causes hepatitis in humans. Humans can become infected by consumption of pork or contact with pigs. Pigs are the main reservoir of the virus worldwide and the virus is present on most pig farms. MAIN BODY: Though HEV is present on most farms, the proportion of infected pigs at slaughter and thus the level of exposure to consumers differs between farms and countries. Understanding the cause of that difference is necessary to install effective measures to lower HEV in pigs at slaughter. Here, HEV studies are reviewed that include infection dynamics of HEV in pigs and on farms, risk factors for HEV farm prevalence, and that describe mechanisms and sources that could generate persistence on farms. Most pigs become infected after maternal immunity has waned, at the end of the nursing or beginning of the fattening phase. Risk factors increasing the likelihood of a high farm prevalence or proportion of actively infected slaughter pigs comprise of factors such as farm demographics, internal and external biosecurity and immunomodulating coinfections. On-farm persistence of HEV is plausible, because of a high transmission rate and a constant influx of susceptible pigs. Environmental sources of HEV that enhance persistence are contaminated manure storages, water and fomites. CONCLUSION: As HEV is persistently present on most pig farms, current risk mitigation should focus on lowering transmission within farms, especially between farm compartments. Yet, one should be aware of the paradox of increasing the proportion of actively infected pigs at slaughter by reducing transmission insufficiently. Vaccination of pigs may aid HEV control in the future.
BACKGROUND: Hepatitis E virus (HEV) genotype 3 and 4 is a zoonosis that causes hepatitis in humans. Humans can become infected by consumption of pork or contact with pigs. Pigs are the main reservoir of the virus worldwide and the virus is present on most pig farms. MAIN BODY: Though HEV is present on most farms, the proportion of infected pigs at slaughter and thus the level of exposure to consumers differs between farms and countries. Understanding the cause of that difference is necessary to install effective measures to lower HEV in pigs at slaughter. Here, HEV studies are reviewed that include infection dynamics of HEV in pigs and on farms, risk factors for HEV farm prevalence, and that describe mechanisms and sources that could generate persistence on farms. Most pigs become infected after maternal immunity has waned, at the end of the nursing or beginning of the fattening phase. Risk factors increasing the likelihood of a high farm prevalence or proportion of actively infected slaughter pigs comprise of factors such as farm demographics, internal and external biosecurity and immunomodulating coinfections. On-farm persistence of HEV is plausible, because of a high transmission rate and a constant influx of susceptible pigs. Environmental sources of HEV that enhance persistence are contaminated manure storages, water and fomites. CONCLUSION: As HEV is persistently present on most pig farms, current risk mitigation should focus on lowering transmission within farms, especially between farm compartments. Yet, one should be aware of the paradox of increasing the proportion of actively infected pigs at slaughter by reducing transmission insufficiently. Vaccination of pigs may aid HEV control in the future.
Authors: Dianjun Cao; Qian M Cao; Sakthivel Subramaniam; Danielle M Yugo; C Lynn Heffron; Adam J Rogers; Scott P Kenney; Debin Tian; Shannon R Matzinger; Christopher Overend; Nicholas Catanzaro; Tanya LeRoith; Heng Wang; Pablo Piñeyro; Nicole Lindstrom; Sherrie Clark-Deener; Lijuan Yuan; Xiang-Jin Meng Journal: Proc Natl Acad Sci U S A Date: 2017-06-19 Impact factor: 11.205
Authors: F Widén; L Sundqvist; A Matyi-Toth; G Metreveli; S Belák; G Hallgren; H Norder Journal: Epidemiol Infect Date: 2010-06-14 Impact factor: 2.451
Authors: Antonia Ricci; Ana Allende; Declan Bolton; Marianne Chemaly; Robert Davies; Pablo Salvador Fernandez Escamez; Lieve Herman; Kostas Koutsoumanis; Roland Lindqvist; Birgit Nørrung; Lucy Robertson; Giuseppe Ru; Moez Sanaa; Marion Simmons; Panagiotis Skandamis; Emma Snary; Niko Speybroeck; Benno Ter Kuile; John Threlfall; Helene Wahlström; Ilaria Di Bartolo; Reimar Johne; Nicole Pavio; Saskia Rutjes; Wim van der Poel; Petra Vasickova; Michaela Hempen; Winy Messens; Valentina Rizzi; Francesca Latronico; Rosina Girones Journal: EFSA J Date: 2017-07-11
Authors: Marina Meester; Martijn Bouwknegt; Renate Hakze-van der Honing; Hans Vernooij; Manon Houben; Sophie van Oort; Wim H M van der Poel; Arjan Stegeman; Tijs Tobias Journal: Vet Res Date: 2022-07-07 Impact factor: 3.829
Authors: Christine Hanssen Rinaldo; Ingebjørg Helena Nymo; Javier Sánchez Romano; Eva Marie Breines; Francisco Javier Ancin Murguzur; Morten Tryland Journal: Pathogens Date: 2021-11-25